# Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelope

**Authors:** Andrew Wilcox-King, Yu-Hsin Wan, Samuel C. Scharffenberger, Crystal B. Chhan, Amelia R. Davis, Leah J. Homad, Emilie Seydoux, Kellie J. MacPhee, Latha Kallur Siddaramaiah, Mariane Melo, Pia Dosenovic, Darrell J. Irvine, Ollivier Hyrien, Leonidas Stamatatos, Andrew T. McGuire

PMC · DOI: 10.1038/s41541-025-01235-5 · NPJ Vaccines · 2025-08-05

## TL;DR

This study shows that priming VRC01-class B cells with non-envelope immunogens is less effective than using HIV-1 envelope proteins for boosting neutralizing antibody responses.

## Contribution

The study compares the effectiveness of non-envelope and envelope-based immunogens in priming VRC01-class B cells for HIV-1 vaccine development.

## Key findings

- The Env-Env regimen led to greater expansion of on-target VRC01 B cells and higher antibody titers.
- Non-Env immunogens drove off-track somatic mutations and off-target Env-specific responses.
- Circulating off-target antibodies can enhance on-target B cell responses through positive feedback.

## Abstract

VRC01-class antibodies are a genetically restricted class of antibodies capable of potently neutralizing diverse strains of HIV-1. Unmutated VRC01 precursors fail to recognize recombinant HIV-1 Envelope (Env) proteins, which necessitated the development of germline targeting vaccine immunogens capable of initiating VRC01-class B cell response. Among these, we developed an anti-idiotypic monoclonal antibody (ai-mAb)-derived VRC01 class targeting immunogen. Because it is distinct from Env, we speculated that the ai-mAb will selectively engage naive VRC01 class B cells while limiting B cell responses directed at off-target epitopes on Env during prime-boost regimens. Here, we evaluated the serum and B cell responses to ai-mAb prime/Env boost, and Env-prime/Env boost regimens in a murine adoptive transfer model where VRC01 precursor B cells are present at physiological levels. We found that the Env-Env regimen led to the greatest expansion of on-target VRC01 B cells, drove larger VRC01-class GC responses, and elicited higher titers of circulating antibodies despite also eliciting substantial off-target Env-specific responses. Single-cell sorting experiments revealed that the ai-mAb was driving off-track somatic mutations. IgG transfer experiments demonstrated that circulating off-target antibodies provide a positive feedback mechanism that potentiates on-target B cell responses. Collectively, the results suggest that non-Env immunogens are not ideal for priming VRC01-class B cells, where sequential boosting with Env will be required to drive maturation of neutralizing breadth.

## Linked entities

- **Proteins:** IGG (Immunoglobulin G level)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Chemicals:** VRC01 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12325944/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12325944/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12325944/full.md

---
Source: https://tomesphere.com/paper/PMC12325944